Financial News Archive

Institutional holdings report (13F-HR) filed by AMF Tjanstepension AB....

Tarsus Pharmaceuticals will acquire Alkeus Pharmaceuticals to obtain gildeuretinol, a Phase 3 oral therapy for Stargardt disease, a leading inherited ...

Sharon AI reported Q2 2026 revenue of $1.9m and a $8.8 billion total contract value, driven by a six-year partnership with NVIDIA and major infrastruc...

Teleflex reported second-quarter 2026 revenue of $570.3 million, up 28.9%, but lowered and adjusted guidance for the full year. The company completed ...

Vistance reported Q2 2026 results with net sales of $319.6 million and revenue down 1.4% year-over-year. The company also announced the final step of ...

Commerce.com announced Q2 2026 revenue of $84.5 million and GAAP net income of $1.1 million, marking consecutive quarterly profitability. The company ...

OpenText unveiled fiscal 2026 results with $1.96B in cloud revenues (+5.5% Y/Y) and adjusted EBITDA margin of 36.3%, focusing on AI and operational di...

Zoetis reported Q2 revenue of $2.5B but slashed full-year guidance, citing softer companion animal market and increased competition. Shares fell 2% pr...

Cullinan Therapeutics released Q2 results and shared clinical data, including plans to begin a potentially registrational Phase 2 study for CLN-049 an...

Resolute Holdings reported a Q2 2026 GAAP net loss of $12.4 million or $(1.53) per share, a significant deterioration from prior year results, while s...

Institutional holdings report (13F-HR) filed by Marcho Partners LLP....

Iovance Biotherapeutics posted record second-quarter revenue of ~$99 million and raised gross margins, while updating investors to expect a review of ...

BlackSky reported strong Q2 2026 revenue of $33.3M, up 50% YoY, fueled by space-based intelligence adoption. The company solidified its backlog with e...

Tecnoglass reported Q2 2026 record revenues of $295.3 million, a 15.6% year-over-year increase, driven by demand gains and price increases to offset r...

Evolent Health reported a 47% increase in Q2 2026 revenue driven by new oncology partnerships, while forecasting 2027 revenue growth of over 25% and a...

Cartesian Therapeutics reported Q2 2026 financials, noting a cash balance of roughly $149 million and a non-dilutive credit facility set to extend run...

GPGI reported Q2 2026 adjusted net sales of $473.2 million and reaffirmed fiscal 2026 guidance, citing record performance at CompoSecure....

Unity Software reported strong second-quarter results driven by a 38% increase in total revenue to $546 million, citing strong demand for Generative A...

Avalo Therapeutics reports 2026 Q2 financials with $472.2M cash and initiates a Phase 3 HS program in 2027, driving significant investor interest in i...

Immunocore Holdings announced $115.9M in Q2 2026 sales for KIMMTRAK, a 18% year-over-year increase. The company reported improved net income for the H...